The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 9, 2003, Pages 866-872

  Kimerling, Michael E ^a,b   Slavuckij, A ^b   Chavers, S ^b   Peremtin, G G ^c   Tonkel, T ^c   Sirotkina, O ^c   Golubchikova, V ^c   Baddeley, A ^d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Tomsk Oblast Tuberculosis Services   (Russian Federation)

^d Med Emergency Relief International   (United Kingdom)

Author keywords

Multidrug resistance; Prisons; Russia; Siberia; TB control; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG SENSITIVITY; EVALUATION; FEMALE; HOME; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PRISON; RISK FACTOR; RUSSIAN FEDERATION; STATISTICAL ANALYSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE; EPIDEMIOLOGIC STUDIES; FEMALE; HOUSING; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SIBERIA; TUBERCULOSIS, PULMONARY;

EID: 0141634040     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kimerling M E, Kluge H, Vezhnina N, et al. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 1999; 3: 451-453.
2. Coninx R, Mathieu C, Debacker M, et al. First line tuberculosis therapy and drug resistant Mycobacterium tuberculosis in prisons. Lancet 1999; 353: 969-973.
3. Portaels F, Rigouts L, Bastian I. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union. Int J Tuberc Lung Dis 1999; 3: 582-588.
4. Aerts A, Habouzit M, Mschiladze L, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 2000; 4: 1104-1110.
5. World Health Organization Global Tuberculosis Programme. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997. WHO/TB/97.229. Geneva: WHO, 1997.
6. Centers for Disease Control and Prevention. Primary multidrug-resistant tuberculosis-Ivanovo Oblast, Russia, 1999. MMWR 1999; 48(30): 661-663.
7. Kimerling M E. The Russian equation: an evolving paradigm in tuberculosis control. Int J Tuberc Lung Dis 2000; 4 (Suppl 2): S160-S167.
8. World Health Organization, Communicable Diseases. Antituberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance Report No. 2, prevalence and trends. WHO/CDS/TB/2000.278. Geneva: WHO, 2000.
9. Bone A, Aerts A, Grzemska M, et al. Tuberculosis control in prisons: a manual for programme managers. WHO/CDS/TB/2000.281. Geneva: STOP TB Department, Communicable Diseases, WHO, 2000.
10. Slavuckij A, Sizaire V, Lobera L, Matthys F, Kimerling M E. Decentralization of the DOTS program within a Russian penitentiary system: how to ensure the continuity of tuberculosis treatment in pre-trial detention centers. Eur J Public Health 2002; 12: 94-98.
11. Fernandez de la Hoz F, Inigo J, Fernandez-Martin J I, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis 2001; 5: 696-702.
12. Mawer C, Ignatenko N V, Wares D F, et al. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculosis regimens in Tomsk, Western Siberia. Lancet 2001; 358: 445-449.
13. Jacobs B, Clowes C, Wares F, et al. Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia. Int J Tuberc Lung Dis 2002; 6: 396-405.
14. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programs. Bull World Health Organ 1969; 41: 21-43.
15. Siddiqi S H, Libonati J P, Middlebrook G. Evaluation of rapid radiometric methods for drug susceptibility testing of M. tuberculosis. J Clin Microbiol 1981; 13: 908-912.
16. Stokes M E, Davis C S, Koch G G. Categorical data analysis using the SAS® System. Cary, NC: SAS Institute Inc., 1995: pp 163-213.
17. Dobbs T, Slutsky A, Mishustin S, et al. DOTS-Plus in Tomsk, Russia: a collaborative initiative for tuberculosis control. Int J Tuberc Lung Dis 2000; 4 (Suppl 2): S238-239.
18. Centers for Disease Control and Prevention. Primary multidrug resistant tuberculosis-Ivanovo Oblast, Russia, 1999. MMWR 1999; 48: 661-664.
19. Fagerhaugh S Y. Mental illness and the tuberculosis patient. Nursing Outlook 1970; 18: 38-41.